Document is current
Any future updates will be listed below
-
Authors
Leite, Gabriela
Rezaie, Ali
Morales, Walter
Weitsman, Stacy
de Freitas Germano, Juliana
Barlow, Gillian M.
Parodi, Gonzalo
Pimentel, Maya L.
Villanueva-Millan, Maria Jesus
Sanchez, Maritza
Ayyad, Sarah
Mathur, Ruchi
Pimentel, Mark
-
Funding
Funding for this research was provided by:
Scott Gray Donor Advised Fund
Gottesdiener Foundation
Tull Family Foundation
DiCecco Family Foundation
- License Information
-
More Information
Article History
Received: 31 May 2024
Accepted: 1 August 2024
First Online: 5 August 2024
Competing interests
: M.P. is a consultant for Ferring Pharmaceuticals Inc., Salvo Health, Dieta Health and Vivante Health Inc. A.R. is a consultant/speaker for and has received grant support from Bausch Health. Cedars-Sinai has a licensing agreement with Gemelli Biotech and Hobbs Medical. A.R., M.P., and R.M. have equity in Gemelli Biotech and Good LFE. M.P. has equity in Dieta Health, Salvo Health and Vivante Health. All other authors report no competing interests.
